Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
BioSkryb Genomicsbioskryb.com · Low evidenceBioSkryb Genomics provides an integrated single-cell multiomics platform that simultaneously analyzes the genome, full-length transcriptome, and surface proteins from individual cells. The company’s patented PTA technology achieves 97% genome coverage, enabling researchers to uncover rare mutations and cell populations for applications in oncology, neurology, diagnostics, and AI-driven precision medicine.
Parse Score